No Data
No Data
No Data
No Data
No Data
Microbiomes Market Size to Grow at a CAGR of 21.95% by 2027, Evolving Opportunities With 4D Pharma Plc, AOBiome LLC, Among Others - Technavio
Yahoo FinanceFeb 21, 2023 08:14
Delisting of Securities of Alberton Acquisition Corporation; Zosano Pharma Corporation; Electric Last Mile Solutions, Inc.; 4D pharma plc; and Enjoy Technology, Inc. from The Nasdaq Stock Market
NEW YORK, July 18, 2022 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the ordinary shares, warrant, unit, and rights of Alberton Acquisition Corporation. Alberton Acquisition Corporation's securities were suspended o
GlobeNewswireJul 19, 2022 04:06
4D Pharma PLC (LBPS) stock Surges Premarket on Positive Interim Results from its Cancer Study
On March 23, 4D Pharma PLC (LBPS) announced positive interim results from the Phase I/II study for the treatment of Renal Cell Carcinoma (RCC). Consequently, the stock surged up in the premarket and was trading at $6.13 at the last check. In the previous trading session on Tuesday, the stock remained in the green with …
Stocks TelegraphMar 23, 2022 19:17
4D pharma appoints John Doyle as CFO
4D Pharma (OTCPK:FRPRF) has appointed John Doyle as Chief Financial Officer. Mr. Doyle most recently served as CFO at Chiasma, a publicly traded biopharmaceutical company acquired by Amryt Pharma in
Seeking AlphaJan 3, 2022 20:18
Small Pharma Strengthens Board With Appointment of Paul Maier as Independent Director
LONDON, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the "Company" or "Small Pharma"), a neuropharmaceutical company focused on psychedelic-assisted therapies, ann
GlobeNewswireNov 19, 2021 03:10
4D pharma to Participate in Jefferies London Healthcare Conference
LEEDS, England--(BUSINESS WIRE)--4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from th
BusinesswireNov 11, 2021 20:11
No Data
No Data